During the last 90 years since the discovery of vitamin E, research has focused on different
properties of this molecule, the focus often depending on the specific techniques and …

The human glycoprotein afamin was discovered as the fourth member of the albumin gene
family. Despite intense research over the last 20 years, our knowledge of afamin's …

Huntington's disease (HD) causes widespread CNS changes and systemic abnormalities
including endocrine and immune dysfunction. HD biomarkers are needed to power clinical …

Objectives: Alzheimer's disease (AD) is the most common cause of dementia in elderly
persons. Since the pathology of AD develops slowly from a preclinical or early phase into a …

The blood-brain barrier (BBB) is a highly selective cellular barrier that tightly controls the
microenvironment of the central nervous system to restrict the passage of substances, which …

In order to gauge the impact of proteomics in discovery of Alzheimer's disease (AD) blood-
based biomarkers, this study had systematically reviewed articles published between 1984 …

Purpose To investigate whether implantation of a glaucoma shunt device leads to
inappropriate accumulation of plasma derived proteins in the aqueous humor. Methods …

Aim Afamin is a liver-produced glycoprotein, a potential early marker of metabolic syndrome.
Here we investigated regulation of afamin in a course of the metabolic disease development …

Vitamin E is a primary chain‐breaking antioxidant that prevents cyclic propagation of lipid
peroxidation. Across species, vitamin E is essential for normal neuromuscular function by …

Background In search of potential early biomarkers for timely prediction of gestational
diabetes mellitus (GDM), we focused on afamin, a vitamin E–binding protein in human …